Related references
Note: Only part of the references are listed.Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality
Anas A. Youssef et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)
Prognostic value of endocan expression in cancers: evidence from meta-analysis
Xing Huang et al.
ONCOTARGETS AND THERAPY (2016)
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
Makoto Meguro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt
Asmaa Ibrahim Gomaa et al.
PLOS ONE (2014)
Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
Kazuaki Ozaki et al.
JOURNAL OF CANCER (2014)
Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis
Jean-Charles Nault et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Recent advances in the treatment of hepatocellular carcinoma
Kunjali T. Padhya et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol et al.
JOURNAL OF HEPATOLOGY (2013)
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
S. J. Schoenleber et al.
BRITISH JOURNAL OF CANCER (2009)
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis
CP Raut et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Share Paper
